Opiate Dependence: Clinical Trials

1 trial for Opiate Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Opiate Dependence: new trials by email Literature Review of Opiate Dependence trials Research Report on Opiate Dependence

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])
Medisorb naltrexone 380 mg, Oral naltrexone to Medisorb naltrexone 380 mg - Alcoholism, Opiate Dependence
Phase 3TerminatedAlkermes, Inc.1082004-08-012010-11-17

Narrower conditions

Alcoholism (1)  ·  Opioid-Related Disorders (1)

Broader conditions

Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Naltrexone (1)  ·  vivitrol (1)

Sponsors

Alkermes, Inc. (1)

Top investigators

Bernard L. Silverman, MD (1)